摘要
目的采用HPLC测定人血浆中尼麦角林主要代谢物10α-甲氧基-6-甲基麦角林-8β-甲醇(MDL)的血药浓度。方法色谱柱为Luna C18柱(250 mm×4.6 mm,10μm),流动相为乙腈-0.01 mol·L^-1磷酸氢二钠(15:85,磷酸调pH3.5),流速为1.0 ml·min^-1,柱温30℃,检测波长为225 nm。结果线性范围为5.0~80.0 ng·ml^-1(r=0.9997,n=7),平均方法回收率分别为93.85%、94.83%、89.84%;日内RSD分别为4.93%、8.23%、10.63%(n=5),日间RSD分别为6.17%、6.13%、8.41%(n=5)。结论该法灵敏、简便、准确,适用于尼麦角林及相关制剂的临床研究。
OBJECTIVE To establish the method for determination of 10α - methoxy - 6 - methylergoline - 8β - methanol ( MDL, a main metabolite of Nicergoline) in human plasma by HPLC. METHODS Chromatographic column was based on Luna C18 (250 mm × 4.6 mm, 10 μm). The mobile phase consisted of acetonitrile: 0.01 mol·L^-1 disodium hydrogen phosphate (15 : 85, pH3.5 )with a flow rate of 1.0 ml·min^-1. The column temperature was 30℃. The detecting wavelength was 225 nm. RESULT The linear range was 5.0 - 80.0 ng·ml^ -1 ( r = 0. 9997, n = 7 ). The average method recovery were 93.85% ,94.83% and 89.84 %. The intra - day RSD were 4.93 %, 8.23 % and 10.63 % ( n = 5 ), and the inter - day RSD were 6.17% ,6.13 % and 8.41% ( n = 5 ). CONCLUSION The method was sensitive, simple, and reliable, and suitable for determination of nicergoline and other correlated dose forms of nicergoline on clinical study.
出处
《华西药学杂志》
CAS
CSCD
北大核心
2009年第5期519-520,共2页
West China Journal of Pharmaceutical Sciences